Leuthner
Birgitta Leuthner, Darmstadt DE
Patent application number | Description | Published |
---|---|---|
20110201081 | Buttiauxella Sp. Phytase Variants - Provided herein are variants of | 08-18-2011 |
20140234490 | BUTTIAUXELLA SP. PHYTASE VARIANTS - Provided herein are variants of | 08-21-2014 |
20150025071 | TETRAHYDRO-QUINAZOLINONE DERIVATIVES AS TANK AND PARP INHIBITORS - Compounds of the formula I | 01-22-2015 |
Birgitta Leuthner, Koln DE
Patent application number | Description | Published |
---|---|---|
20090208440 | BIOLOGICAL ENTITIES AND THE USE THEREOF - The present invention provides engineered enzymes generated from protein scaffolds combined with Specificity Determining Regions, the production thereof and the use of said engineered enzymes for research, nutritional care, personal care and industrial purposes. | 08-20-2009 |
Birgitta Leuthner, Lagenfeld DE
Patent application number | Description | Published |
---|---|---|
20090098249 | Variant Buttiauxella sp. Phytases having altered properties - The present invention relates to variant phytase enzymes having altered properties. | 04-16-2009 |
Birgitta Leuthner, Cologne DE
Patent application number | Description | Published |
---|---|---|
20090074925 | ENZYMES - The present invention relates to enzymes and processes. In particular, there is described an isolated polypeptide comprising the amino acid sequence corresponding to | 03-19-2009 |
20120064194 | ENZYMES - The present invention relates to enzymes and processes. In particular, there is described a host 3140 cell transformed or transfected with a nucleic acid encoding a bacterial phytase enzyme and variants thereof. | 03-15-2012 |
20120301578 | ENZYMES - The present invention relates to enzymes and processes. In particular, there is described an isolated polypeptide comprising the amino acid sequence corresponding to | 11-29-2012 |
20130136825 | ENZYMES - The present invention relates to enzymes and processes. In particular, there is described an isolated polypeptide comprising the amino acid sequence corresponding to | 05-30-2013 |
Birgitta Leuthner, Langenfeld DE
Birgitta Leuthner, Lengenfeld DE
Patent application number | Description | Published |
---|---|---|
20080220498 | Variant Buttiauxella sp. phytases having altered properties - The present invention relates to variant phytase enzymes having altered properties. | 09-11-2008 |
Brian Leuthner, Summit, NJ US
Patent application number | Description | Published |
---|---|---|
20080305147 | Drug Delivery System For The Prevention Of Cerebral Vasospasm - The present invention relates to the treatment and prevention of vasospasm. The present invention provides a system for treating a cerebral vasospasm in a human utilizing a pharmaceutical composition and administrating a therapeutically effective amount of the pharmaceutical composition to a predetermined location in close proximity to a cerebral artery within a subarachnoid space wherein the pharmaceutical composition produces a localized pharmacologic effect thereby treating the cerebral vasospasm. | 12-11-2008 |
Brian A. Leuthner, Summit, NJ US
Patent application number | Description | Published |
---|---|---|
20120164226 | Compositions and Methods for Improving Prognosis of a Human with Subarachnoid Hemorrhage - The described invention provides a pharmaceutical composition, delivery system and a method for treating a delayed complication associated with a brain injury in a mammal and improving its prognosis in a mammal by implanting a therapeutically effective amount of the pharmaceutical composition containing a voltage-gated calcium channel blocker and a pharmaceutically acceptable carrier into a predetermined location in the brain, which reduces signs or symptoms of at least one delayed complication associated with brain injury. | 06-28-2012 |
20120245561 | INTRAVENTRICULAR DRUG DELIVERY SYSTEM FOR IMPROVING OUTCOME AFTER A BRAIN INJURY AFFECTING CEREBRAL BLOOD FLOW - The described invention provides a flowable sustained release microparticulate composition, a kit for treating at least one cerebral artery in a subarachnoid space at risk of interruption due to a brain injury, a method of preparing the composition, and a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury. | 09-27-2012 |
20130022660 | DRUG DELIVERY SYSTEM FOR THE PREVENTION OF CEREBRAL VASOSPASM - The present invention relates to the treatment and prevention of vasospasm. The present invention provides a system for treating a cerebral vasospasm in a human utilizing a pharmaceutical composition and administrating a therapeutically effective amount of the pharmaceutical composition to a predetermined location in close proximity to a cerebral artery within a subarachnoid space wherein the pharmaceutical composition produces a localized pharmacologic effect thereby treating the cerebral vasospasm. | 01-24-2013 |
Brigitta Leuthner, Darmstadt DE
Patent application number | Description | Published |
---|---|---|
20130316955 | AMINOSTATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS - The present invention relates to compounds of the formula (I) and in particular medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia. | 11-28-2013 |